Treatment of extensive stage small cell lung cancer.

4Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Over the past twenty years combination chemotherapy has continued to produce small survival gains for patients with SCLC. We enter the next century enthusiastic about the array of new chemotherapeutic agents to evaluate and fascinated by the biological agents with the hope of achieving dramatic improvements in survival for our patients with SCLC.

Cited by Powered by Scopus

Small-cell lung cancer: An update on targeted therapies

41Citations
N/AReaders
Get full text

The future of cyclooxygenase-2 inhibitors and other inhibitors of the eicosanoid signal pathway in the prevention and therapy of lung cancer

17Citations
N/AReaders
Get full text

A phase I trial of a 5-day schedule of intravenous topotecan and etoposide in previously untreated patients with small-cell lung cancer

13Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Kelly, K. (2001). Treatment of extensive stage small cell lung cancer. Cancer Treatment and Research. https://doi.org/10.1007/978-1-4615-1589-0_10

Readers over time

‘13‘16‘18‘19‘23‘2400.751.52.253

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

50%

Researcher 2

33%

Professor / Associate Prof. 1

17%

Readers' Discipline

Tooltip

Medicine and Dentistry 2

40%

Computer Science 1

20%

Nursing and Health Professions 1

20%

Psychology 1

20%

Save time finding and organizing research with Mendeley

Sign up for free
0